Jul 1 |
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
|
Jun 12 |
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
Jun 12 |
Connect Biopharma appoints Barry Quart as CEO
|
Jun 12 |
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
|
Jun 9 |
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) top owners are private equity firms with 39% stake, while 22% is held by insiders
|
May 22 |
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
|
May 7 |
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
|
May 2 |
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
|
Apr 17 |
Pfizer-Connect Biopharma deal for anti-inflammatory agent ends
|
Apr 16 |
Connect Biopharma GAAP EPS of -$2.15 misses by $1.33
|